Literature DB >> 16282494

Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.

Jianxin You1, Michal-Ruth Schweiger, Peter M Howley.   

Abstract

The bovine papillomavirus E2 protein tethers the viral genomes to mitotic chromosomes in dividing cells through binding to the C-terminal domain (CTD) of Brd4. Expression of the Brd4-CTD competes the binding of E2 to endogenous Brd4 in cells. Here we extend our previous study that identified Brd4 as the E2 mitotic chromosome receptor to show that Brd4-CTD expression released the viral DNA from mitotic chromosomes in BPV-1 transformed cells. Furthermore, stable expression of Brd4-CTD enhanced the frequency of morphological reversion of BPV-1 transformed C127 cells resulting in the complete elimination of the viral DNA in the resulting flat revertants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282494      PMCID: PMC1287565          DOI: 10.1128/JVI.79.23.14956-14961.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Interaction of the papillomavirus E2 protein with mitotic chromosomes.

Authors:  N Bastien; A A McBride
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.

Authors:  Anup Dey; Farideh Chitsaz; Asim Abbasi; Tom Misteli; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

3.  Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes.

Authors:  Jianxin You; Jennie L Croyle; Akiko Nishimura; Keiko Ozato; Peter M Howley
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

4.  The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.

Authors:  Michael K Baxter; Maria G McPhillips; Keiko Ozato; Alison A McBride
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.

Authors:  D R Lowy; I Dvoretzky; R Shober; M F Law; L Engel; P M Howley
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

6.  A quantitative in vitro focus assay for bovine papilloma virus.

Authors:  I Dvoretzky; R Shober; S K Chattopadhyay; D R Lowy
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

Review 7.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

8.  Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein.

Authors:  Aare Abroi; Ivar Ilves; Sirje Kivi; Mart Ustav
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.

Authors:  S C Hung; M S Kang; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  36 in total

1.  HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.

Authors:  Jiangfang Wang; Emma L Reuschel; Jason M Shackelford; Lauren Jeang; Debra K Shivers; J Alan Diehl; Xiao-Fang Yu; Terri H Finkel
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

Review 2.  Hitchhiking on host chromatin: how papillomaviruses persist.

Authors:  Alison A McBride; Nozomi Sakakibara; Wesley H Stepp; Moon Kyoo Jang
Journal:  Biochim Biophys Acta       Date:  2012-01-28

3.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.

Authors:  Jianxin You; Viswanathan Srinivasan; Gerald V Denis; William J Harrington; Mary E Ballestas; Kenneth M Kaye; Peter M Howley
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.

Authors:  M G McPhillips; J G Oliveira; J E Spindler; R Mitra; A A McBride
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 7.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

8.  The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.

Authors:  Matthias Ottinger; Daniel Pliquet; Thomas Christalla; Ronald Frank; James P Stewart; Thomas F Schulz
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

9.  Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1.

Authors:  David Gagnon; Hélène Sénéchal; Claudia M D'Abramo; Jennifer Alvarez; Alison A McBride; Jacques Archambault
Journal:  Virology       Date:  2013-03-11       Impact factor: 3.616

10.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.